Track the POLYNOVO LIMITED stock price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on AU AU, under the authority of ASX. Market capitalisation: €635.6m. The full history is openly available.
Analysts rate POLYNOVO LIMITED Strong Buy (bullish), based on 8 analysts. Average price target: A$1.70.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
POLYNOVO LIMITED is an Australian company focused on the development of medical devices, particularly products for wound management. It is listed on the Australian Securities Exchange under the ticker ASX.